Publication | Closed Access

Survival benefit for early hormone ablation in biochemically recurrent prostate cancer

Survival BenefitUrologySurgical OncologyGenitourinary CancerMedicineProstatic DiseaseEarly Hormone AblationOncologyRadiation OncologyRecurrent Prostate CancerEndocrine-related Cancer